Tissue confirmation of disease recurrence in breast cancer patients: Pooled analysis of multi-centre, multi-disciplinary prospective studies-Reference-Cited by-同舟云学术

Tissue confirmation of disease recurrence in breast cancer patients: Pooled analysis of multi-centre, multi-disciplinary prospective studies

Published:2012-10 Issue:6 Volume:38 Page:708-714
ISSN:0305-7372
Container-title:Cancer Treatment Reviews
language:en
Short-container-title:Cancer Treatment Reviews

Author:

Amir Eitan,Clemons Mark,Purdie Colin A.,Miller Naomi,Quinlan Phil,Geddie William,Coleman Robert E.,Freedman Orit C.,Jordan Lee B.,Thompson Alastair M.

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Reference34 articles.

1. Intratumor genetic heterogeneity of breast carcinomas as determined by fine needle aspiration and TaqMan low density array;Lyng;Cell Oncol,2007

2. Intratumor heterogeneity and precision of microarray-based predictors of breast cancer biology and clinical outcome;Barry;J Clin Oncol,2010

3. Breast cancer molecular profiling with single sample predictors: a retrospective analysis;Weigelt;Lancet Oncol,2010

4. The variability of estrogen receptors in metastatic breast cancer;Brennan;Am J Surg,1979

5. Variation in receptor status between primary and metastatic breast cancer;Holdaway;Cancer,1983

Cited by 151 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Receptor Discordance in Metastatic Breast Cancer; a review of clinical and genetic subtype alterations from primary to metastatic disease;Breast Cancer Research and Treatment;2024-08-01

2. A retrospective study of do-not-do practice recommendations in metastatic breast cancer in Spain;Revista de Senología y Patología Mamaria;2024-07

3. Retrospective analysis of estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor-2 (HER2), Ki67 changes and their clinical significance between primary breast cancer and metastatic tumors;PeerJ;2024-05-15

4. Oncotype DX in Breast Cancer Management: Insights and Outcomes From the United Arab Emirates;Cureus;2024-03-20

5. Issues Facing the Established Metastatic Bone Disease Patient: Timing/Indications for Surgery;Metastatic Bone Disease;2024